+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
NATCAPSUQ

Natural Capsules Share Price

 
Near 52W Low of ₹136.36

 

Natural Capsules live price: ₹142.50. It opened at ₹142 vs previous close ₹142; intraday high/low: ₹143/₹142. The 50 & 200 DMA stand at ₹152.50/₹169.90.

Natural Capsules Performance

  • Today's Low
  • ₹142
  • Today's High
  • ₹143
  • 52 Week Low
  • ₹136
  • 52 Week High
  • ₹296
  • Open Price₹142
  • Previous Close₹142
  • Volume255
  • 50 DMA₹152.50
  • 100 DMA₹157.80
  • 200 DMA₹169.90

Natural Capsules Chart

Investment Returns

  • Over 1 Month -5.81%
  • Over 3 Month -15.22%
  • Over 6 Month -21.49%
  • Over 1 Year -34.67%

Smart Investing Starts Here Start SIP with Natural Capsules for Steady Growth!

Invest Now

Natural Capsules Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -6.4
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 148
  • P/B Ratio
  • 0.7
  • Average True Range
  • 6.7
  • EPS
  • -22.2
  • Dividend Yield
  • 0
  • MACD Signal
  • -3.7
  • RSI
  • 36.98
  • MFI
  • 15.43

Latest Stock News Updates

Natural Capsules Ltd - 524654 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 - Copy of Newspaper Advertisement, i.e. Notice for attention of equity shareholders of the Company.

Natural Capsules Ltd - 524654 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we hereby submit the certificate received from Cameo Corporate Services Limited, Registrar & Share Transfer Agent ("RTA") for the quarter ended June 30, 2026.

Natural Capsules Ltd - 524654 - Intimation Under Regulation 30(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

This is to inform you that under Regulation 30(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; Natural Biogenex Private Limited ("Material Unlisted Subsidiary"), at its Board Meeting held on today, i.e, July 10th, 2026, has approved the right issue of 11,16,766 equity shares of Rs. 10 each for cash at par, aggregating to Rs. 1,11,67,660 (Rupees One Crore Eleven Lakh Sixty-Seven Thousand Six Hundred and Sixty Only).

Natural Capsules Financials

Natural Capsules Technicals

EMA & SMA

Current Price
₹142.50
+ 0.39 (0.27%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹148.20
  • 50 Day
  • ₹152.50
  • 100 Day
  • ₹157.80
  • 200 Day
  • ₹169.90

Resistance and Support

142.67 Pivot Speed
  • R3 149.90
  • R2 148.00
  • R1 145.00
  • S1 140.20
  • S2 138.20
  • S3 135.30

Natural Capsules Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-27 Audited Results
2026-02-13 Quarterly Results
2025-11-13 Quarterly Results
2025-08-04 Quarterly Results
2025-05-29 Audited Results

Natural Capsules Shareholding Pattern

50.92%
49.09%
0%

About Natural Capsules

Natural Capsules is a wellequipped modern manufacturing plant to manufacture Hard Gelatin Capsule shells, Hard Cellulose Capsule shells and Pharmaceutical Dosage Forms in Capsule .Dosage Form. View More
  • NSE Symbol
  • NATCAPSUQ
  • BSE Symbol
  • 524654
  • ISIN
  • INE936B01015

Similar Stocks to Natural Capsules

Natural Capsules FAQs

Natural Capsules share price is ₹142 As on 17 July, 2026 | 13:21

The Market Cap of Natural Capsules is ₹148.4 Cr As on 17 July, 2026 | 13:21

The P/E ratio of Natural Capsules is -6.4 As on 17 July, 2026 | 13:21

The PB ratio of Natural Capsules is 0.7 As on 17 July, 2026 | 13:21

The 52 week High & Low of Natural Capsules is ₹296/₹136.4 respectively As on 17 July, 2026 | 13:21

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23